Riskpilot← Back to searchSign inGet full accessLäkarhusen i Väst AB
ABActiveOrg 5591569305Svenstorpsvägen 15General medical practice activities · NACE 8621Est. 201832 employees
Revenue 2025
SEK 39,5M
+28% vs 2024
EBITDA margin
7.2%
+470% vs 2024
Equity ratio
36.7%
Financial strength
Net profit 2025
SEK 1M
+218% vs 2024
| Revenue | SEK 39,5M | +28% |
| EBITDA | SEK 2,8M | +470% |
| Net profit | SEK 1M | +218% |
| Total assets | SEK 8,7M | +4% |
| Equity | SEK 3,2M | -32% |
| Employees | 32 | — |
Legal name
Läkarhusen i Väst AB
Org number
5591569305
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
25 april 2018
Share capital
SEK 50 000
Employees
32 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Företaget ska bedriva vårdverksamhet, konsulttjänster inom vård och ledarskap, uthyrning av personal inom vårdsektorn.
Address
Svenstorpsvägen 15
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 35 710 | 33 367 | 30 504 | 30 782 | 39 537 |
| Staff expenses | — | −17 014 | −17 558 | −19 674 | −21 963 |
| EBITDA | 6 528 | 5 047 | 2 544 | 499 | 2 842 |
| Depreciation & amort. | −658 | −711 | −714 | −286 | −279 |
| EBIT | 5 870 | 4 336 | 1 831 | 213 | 2 563 |
| Net financials | −1 | −5 | 22 | 5 | −2 |
| Profit before tax | 4 869 | 290 | 1 838 | 442 | 1 331 |
| Tax | −1 026 | −78 | −395 | −117 | −301 |
| Net profit | 3 843 | 212 | 1 443 | 324 | 1 030 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 12 109 | 10 619 | 9 809 | 8 337 | 8 698 |
| Equity | 4 686 | 2 898 | 4 341 | 4 666 | 3 196 |
| Long-term debt | 0 | — | — | — | 1 500 |
| Short-term debt | 6 490 | 6 788 | 4 630 | 3 057 | 2 908 |
| Total debt | 6 490 | 6 788 | 4 630 | 3 057 | 4 408 |
EBITDA margin
7.2%
This company
15.8%
Market median
-54% vs market
20212025
Equity ratio
36.7%
This company
38.2%
Market median
+4% vs market
20212025
Return on equity
32.2%
This company
18.4%
Market median
+75% vs market
20212025
Net profit margin
2.6%
This company
8.1%
Market median
-68% vs market
20212025
Asset turnover
4.55×
This company
1.12×
Market median
+306% vs market
20212025
Debt / equity
1.72×
This company
0.62×
Market median
-177% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EG Chief Auditor | Chief Auditor | 2025 |
| Former (2) | ||
AM Chief Auditor | Chief Auditor | 2025 – 2025 |
BH Audit | Audit | 2021 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2021 | |
| Chairman | 2021 | |
| Deputy Board Member | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SPEKAEL AB
Läkarhusen i Väst AB Board members of Läkarhusen i Väst AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Mikaela Hedin Göran | Chief Auditor | 0 companies |
| Bo Helge Eugén Östh | Audit | 0 companies |
| Erik Gunnar Hansson | Chief Auditor | 0 companies |
| Karin Therese Svensson Stolt | Board of Directors | 0 companies |
| Rolf Mikael Spetz | Chairman | 0 companies |
| Marianne Sofia Spetz | Deputy Board Member | 0 companies |